GGrantIndex
Sort

23,748 grants matching melanoma

PH I &II: AUTOLOGOUS DENDRITIC CELLS INDUCTION OF ANTITUMOR IMMUNITY

$293,069
Duke University · M01 · FY2001 · RR

Core 2: ImmunoPhenotyping Core

$293,016
Ata Saba Moshiri · University Of Washington · P01 · FY2023 · CA

Validation of genomic targets in melanoma

$293,015
Mohammed Kashani-Sabet · University Of California, San Francisco · R01 · FY2006 · CA

An RNA Sensor for Detection of Circulating Tumor Cells

$293,000
Gary A Clawson · Pennsylvania State Univ Hershey Med Ctr · R33 · FY2006 · CA

TCR Affinity and Therapeutic Efficacy of T Cells

$292,953
Michael I Nishimura · Medical University Of South Carolina · R01 · FY2009 · CA

Regulation by Immune Response to Vaccine by Botanicals

$292,942
Sloan-Kettering Institute For Cancer Res · P50 · FY2005 · AT

Pathways from genotype and environment to melanoma

$292,942
Nicholas K Hayward · Queensland Institute Of Medical Research · R01 · FY2008 · CA

Biomarkers of the Proinflammatory Response and Elements of Immune Suppression

$292,902
Ahmad A. Tarhini · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · CA

CLINICAL DEVELOPMENT OF HU14.18 IL2 TARGETED THERAPY

$292,837
University Of Wisconsin Madison · R01 · FY2001 · CA

Project 4: Immunovirotherapy

$292,832
Richard G Vile · Mayo Clinic Rochester · P50 · FY2019 · CA

Subpopulations of Human Dendritic Cells

$292,811
Jacques F Banchereau · Baylor Research Institute · R01 · FY2007 · CA

Subpopulations of Human Dendritic Cells

$292,811
Jacques F Banchereau · Baylor Research Institute · R01 · FY2008 · CA

TCR Affinity and Therapeutic Efficacy of T Cells

$292,809
Michael I Nishimura · Medical University Of South Carolina · R01 · FY2008 · CA

Cancer Epigenetics Training Program

$292,785
Maria Eugenia Figueroa · University Of Miami School Of Medicine · T32 · FY2020 · CA

Clinical Development of HU14.18-IL2 Targeted Therapy

$292,778
Paul M Sondel · University Of Wisconsin-Madison · R01 · FY2013 · CA

CELL ADHESION AND SIGNAL TRANSDUCTION IN DROSOPHILA

$292,769
University Of North Carolina Chapel Hill · R01 · FY2001 · GM

Elucidating the Function of the NF1 tumor suppressor and its effector pathways in

$292,751
Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2010 · CA

IL-12 as an Adjuvant for a Melanoma Peptide Vaccine

$292,747
University Of Southern California · R01 · FY2003 · CA

LPD Nanoparticles in Anti-Cancer Therapy

$292,676
Leaf Huang · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA

PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN

$292,600
James S. Economou · University Of California Los Angeles · R01 · FY2010 · CA

PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN

$292,600
James S. Economou · University Of California Los Angeles · R01 · FY2008 · CA

PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN

$292,600
James S. Economou · University Of California Los Angeles · R01 · FY2009 · CA

Advanced machine learning to empower ultra-sensitive liquid biopsy in melanoma and non-small cell lung cancer

$292,597
Adam Widman · Sloan-Kettering Inst Can Research · K08 · FY2025 · CA

Advanced machine learning to empower ultra-sensitive liquid biopsy in melanoma and non-small cell lung cancer

$292,597
Adam Widman · Sloan-Kettering Inst Can Research · K08 · FY2024 · CA

Advanced machine learning to empower ultra-sensitive liquid biopsy in melanoma and non-small cell lung cancer

$292,597
Adam Widman · Sloan-Kettering Inst Can Research · K08 · FY2023 · CA